P

Inventor

BOCK MARK G

US92 patents
⚠️ This page may combine multiple inventors who share the name “BOCK MARK G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MERCK & CO INC

44 patents
US4820834AApr 11, 1989

Benzodiazepine analogs

MERCK & CO INC161 citations99
US5464788ANov 7, 1995

Tocolytic oxytocin receptor antagonists

MERCK & CO INC135 citations98
US5324726AJun 28, 1994

Benzodiazepine analogs

MERCK & CO INC137 citations98
US5756504AMay 26, 1998

Tocolytic oxytocin receptor antagonists

MERCK & CO INC112 citations97
US5665719ASep 9, 1997

Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists

MERCK & CO INC74 citations96
US5206234AApr 27, 1993

Benzolactam analogs as antagonists of cck

MERCK & CO INC61 citations96
US5004741AApr 2, 1991

Methods of antagonizing CCK or gastrin with benzodiazepine analogs

MERCK & CO INC59 citations96
US4309430AJan 5, 1982

Pyrazinyl-1,2,4-oxadiazole-5-ones, for treatment of edema, and processes for preparing same

MERCK & CO INC53 citations96
US5220018AJun 15, 1993

Cholecystokinin antagonists

MERCK & CO INC29 citations93
US5220017AJun 15, 1993

Cholecystokinin antagonists

MERCK & CO INC36 citations93
US5210082AMay 11, 1993

2-benzazepines with 5- and 6-membered heterocyclic rings to treat pain and anxiety disorders

MERCK & CO INC25 citations93
US5185331AFeb 9, 1993

Triazolobenzodiazepines

MERCK & CO INC23 citations93
US5177071AJan 5, 1993

1,4-benzodiazepines with 6-membered heterocyclic rings to treat panic and anxiety disorder

MERCK & CO INC47 citations93
US5175159ADec 29, 1992

3-substituted-1,4-benzodiazepines as oxytocin antagonists

MERCK & CO INC36 citations93
US5166151ANov 24, 1992

2-Benzazepines with 5- and 6-membered heterocyclic rings, compositions and medical methods of use thereof

MERCK & CO INC41 citations93
US4812442AMar 14, 1989

Tripeptide renin inhibitors

MERCK & CO INC26 citations93
US4755508AJul 5, 1988

Benzodiazepine analogs and use as antogonists of gastrin and cholecystokinin

MERCK & CO INC49 citations93
US4479941AOct 30, 1984

Renin inhibitory peptides having PHE13 delection

MERCK & CO INC33 citations93
US4362724ADec 7, 1982

Method of treating edema and hypertension and pharmaceutical composition therefor in which the active ingredient comprises a novel substituted pyrazinyl-1,2,4-oxadiazole and a kaliuretic diuretic

MERCK & CO INC40 citations93
US4145551AMar 20, 1979

Pyrazine-2-carbonyloxyguanidines

MERCK & CO INC49 citations93
US6436962B1Aug 20, 2002

Arylhydantoin derivatives and uses thereof

MERCK & CO INC34 citations92
US5834464ANov 10, 1998

Imidazolinobenzodiazepines

MERCK & CO INC29 citations92
US5439906AAug 8, 1995

Antiarrhythmic benzodiazepines

MERCK & CO INC24 citations92
US4636491AJan 13, 1987

Renin inhibitory peptides having improved solubility

MERCK & CO INC26 citations92
US4628084ADec 9, 1986

Process for 3-acylamino benzodiazepines

MERCK & CO INC28 citations92
US6919343B2Jul 19, 2005

N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives

MERCK & CO INC14 citations83
US4554272ANov 19, 1985

Substituted quinazolino-1,4-benzodiazepin-6,9-diones and their preparation

MERCK & CO INC20 citations82
US4454132AJun 12, 1984

Pharmaceutical compositions of novel substituted pyrazinyl-1,2,4-oxadiazoles useful in the treatment of edema and hypertension

MERCK & CO INC22 citations82
US4309540AJan 5, 1982

Substituted pyrazinyl-1,2,4-oxadiazoles

MERCK & CO INC28 citations82
US5620993AApr 15, 1997

Alpha-1a adrenergic receptor antagonists

MERCK & CO INC17 citations80
US6908921B2Jun 21, 2005

Quinoxalinone derivatives as bradykinin B1 antagonists

MERCK & CO INC7 citations74
US6255315B1Jul 3, 2001

Alpha 1a adrenergic receptor antagonists

MERCK & CO INC11 citations74
US6143750ANov 7, 2000

Alpha 1a adrenergic receptor antagonists

MERCK & CO INC8 citations74
US6037354AMar 14, 2000

Alpha 1a adrenergic receptor antagonists

MERCK & CO INC6 citations74
US5378838AJan 3, 1995

Benzodiazepine cholecystokinin antagonists

MERCK & CO INC8 citations74
US5225528AJul 6, 1993

Cyclic hexapeptide oxytocin antagonists

MERCK & CO INC14 citations74
US4847248AJul 11, 1989

1,4-Benzodiazepines with 5- and 6-membered heterocyclic rings and their use as cholecystokinins and gastrin antagonists

MERCK & CO INC19 citations74
US4724237AFeb 9, 1988

2-substituted-aminomethyl-1,4-benzodiazepines

MERCK & CO INC8 citations74
US4663310AMay 5, 1987

Renin inhibitors containing 2-substituted statine

MERCK & CO INC11 citations74
US4663321AMay 5, 1987

Triazolobenzodiazepines and pharmaceutical use

MERCK & CO INC17 citations74
US4661473AApr 28, 1987

Renin inhibitors containing peptide isosteres

MERCK & CO INC19 citations74
US4559339ADec 17, 1985

Indol-3-yl-quinazolino-1,4-benzodiazepin-5,13-diones

MERCK & CO INC7 citations74
US5218114AJun 8, 1993

Cholecystokinin antagonists

MERCK & CO INC15 citations73
US4487963ADec 11, 1984

Enantioselective synthesis of 4-amino-3-hydroxy-2,4-(disubstituted)pentanoic acid

MERCK & CO INC7 citations73

BEBERNITZ GREGORY RAYMOND

3 patents

MERCK SHARP & DOHME

1 patent

BOCK MARK G

1 patent

SALK INST FOR BIOLOGICAL STUDI

1 patent

Showing the top 50 of 92 patents by PatentIndex Score.